Australian Pharmaceutical Industries Ltd
ASX:API
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Goodman Property Trust
NZX:GMT
|
NZ |
|
Shriram Finance Ltd
NSE:SHRIRAMFIN
|
IN |
|
Scandi Standard AB (publ)
STO:SCST
|
SE |
|
L
|
Lyckegard Group AB
STO:LYGRD
|
SE |
|
KEPCO Plant Service & Engineering Co Ltd
KRX:051600
|
KR |
API's latest stock split occurred on Oct 21, 2009
The company executed a 788-for-667 stock split, meaning that for every 667 shares held, investors received 788 new shares.
Before the split, API traded at 0.893 per share. Afterward, the share price was about 0.4757.
The adjusted shares began trading on Oct 21, 2009. This was the only stock split in API's history.
Global
Stock Splits Monitor
Australian Pharmaceutical Industries Ltd
Glance View
Australian Pharmaceutical Industries Ltd. engages in the wholesale, product delivery, retail services, marketing programs and business advisory services. The company is headquartered in Melbourne, Victoria. The Company’s segments include Australia and New Zealand. The Australia segment is engaged in distribution of pharmaceutical, medical, health, beauty and lifestyle products and retail services to pharmacies, the purchase and sale of health, beauty and lifestyle products and services within the retail industry, including cosmetic products and non-invasive procedures. The New Zealand segment manufactures and owns rights for pharmaceutical medicines and consumer toiletries. The firm's brands include Priceline & Priceline Pharmacy, which is a health, beauty and wellbeing retailer; Soul Pattinson Chemist, which is a pharmacy brand; Pharmacist Advice, which offers professional service and advice; Club Premium, which is a club for independent pharmacies, and Pharmacy Best Buys, which offers a catalog program.
300033
RMDRIP
WWI